Pharmaceuticals · Sales VP · Long Time No Contact
Thank You for Pharmaceuticals Sales VP: Long Time No Contact
A thank-you email for a Pharmaceuticals Sales VP (long time no contact) is a short message that reopens the thread without making them do extra work. A thank-you email names the specific thing someone did and, when it's natural, points to one next step without turning gratitude into a pitch. In this setting, that means speaking to follow-up that ignores
Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors
We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.
Sources: HubSpot sales email benchmarks; Gong follow-up research
Why does this thank you work for a Pharmaceuticals Sales VP?
- Send it while the moment is still in their memory.
- Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
- Fits how a sales VP actually reads: 70 to 90 words. Lead with the outcome.
- Bring a new observation about their world, then offer a small, optional next step.
- Reflect back one insight they shared.
When should I send this to a Pharmaceuticals Sales VP?
Send it the same day. Thanks that arrive a week later feel like a task. Send when you have a real trigger: news, a useful artifact, a role change, a season. For this combo, treat "Only when you have a trigger" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a sales VP, 70 to 90 words. Lead with the outcome.
What this Sales VP actually cares about
A sales VP in Pharmaceuticals is protecting quota, forecast credibility, and rep time. They think in pipeline, ramp, and forecast risk. If you can't map your email to a number they already report, it feels like a hobby. The hook that earns a look is a stage in the funnel that's leaking, a slow follow-up SLA, or a ramp problem. The ask should stay at this size: a 15-minute look at one metric, not a platform tour. Delete trigger: Telling them how to sell. They've heard it. Tone: Crisp and commercial. They can handle a direct ask.
How Pharmaceuticals changes the note
Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Proof that lands: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft.
How should I customize this template before I send it?
- Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
- Keep the tone crisp and commercial.
- Don't BCC a thank-you. If others should see it, CC them honestly.
- Time it for Only when you have a trigger. Send when you have a real trigger: news, a useful artifact, a role change, a season.
- Don't use consumer-startup slang. It's a credibility leak.
What mistakes should I avoid with this long time no contact note?
- A generic 'thanks for your time' is forgettable.
- Don't open with 'it's been a while' and then paste the old pitch.
- Don't use consumer-startup slang. It's a credibility leak.
- Telling them how to sell. They've heard it.
How does this long time no contact scenario compare?
| Dimension | For this template |
|---|---|
| Best send window | Only when you have a trigger |
| Ideal length | 70 to 90 words. Lead with the outcome. |
| Primary ask | a 15-minute look at one metric, not a platform tour |
| Industry metric to cite | time through MLR, access, and compliant engagement rates |
| Tone | Crisp and commercial. They can handle a direct ask. |
| Unlike no response | This isn't a 4-day bump. It's a re-introduction with a new reason. |
| Unlike breakup | You're opening a door, not closing one. Still keep it easy to ignore. |
What should I copy and send?
Copy-ready template
Subject
Thanks for the straight talk on [topic]
Body
Hi [First Name], I appreciated how direct you were about [topic] today. The version of this that matters for commercial, medical, and ops leads who work under review boards and long timelines is cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. I took [their advice] and [what you'll do next]. I'll send a short update once that's done. Given this is long time no contact, ask if the old problem still exists, or if you should leave it archived. If I can return the favor, say the word. Best, [Your Name] [Your Title] [Your Company]
Questions people ask before they hit send
Name the situation and the business object, not your excitement. Something like "Thanks for the straight talk on [topic]" outperforms "Just checking in" because a sales VP can decide from the preview text whether it's worth opening. Keep it under 50 characters when you can.
Related templates
Want a custom draft instead? Try the email generator.